Copyright Reports & Markets. All rights reserved.

Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy -Global Market Status and Trend Report 2016-2026

Request for Sample of this report
Buy now

Table of Contents

    Chapter 1 Overview of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy

    • 1.1 Definition of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy in This Report
    • 1.2 Commercial Types of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
      • 1.2.1 Allogeneic CAR T-Cells
      • 1.2.2 Autologous CAR T-Cells
    • 1.3 Downstream Application of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
      • 1.3.1 Hospital
      • 1.3.2 Diagnostic Center
      • 1.3.3 Others
    • 1.4 Development History of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
    • 1.5 Market Status and Trend of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy 2016-2026
      • 1.5.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status and Trend 2016-2026
      • 1.5.2 Regional Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status and Trend 2016-2026

    Chapter 2 Global Market Status and Forecast by Regions

    • 2.1 Market Development of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy 2016-2021
    • 2.2 Production Market of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Regions
      • 2.2.1 Production Volume of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Regions
      • 2.2.2 Production Value of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Regions
    • 2.3 Demand Market of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Regions
    • 2.4 Production and Demand Status of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Regions
      • 2.4.1 Production and Demand Status of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Regions 2016-2021
      • 2.4.2 Import and Export Status of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Regions 2016-2021

    Chapter 3 Global Market Status and Forecast by Types

    • 3.1 Production Volume of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Types
    • 3.2 Production Value of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Types
    • 3.3 Market Forecast of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Types

    Chapter 4 Global Market Status and Forecast by Downstream Industry

    • 4.1 Demand Volume of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Downstream Industry
    • 4.2 Market Forecast of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Downstream Industry

    Chapter 5 Market Driving Factor Analysis of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy

    • 5.1 Global Economy Situation and Trend Overview
    • 5.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Downstream Industry Situation and Trend Overview

    Chapter 6 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Competition Status by Major Manufacturers

    • 6.1 Production Volume of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Major Manufacturers
    • 6.2 Production Value of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Major Manufacturers
    • 6.3 Basic Information of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Major Manufacturers
      • 6.3.1 Headquarters Location and Established Time of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Manufacturer
      • 6.3.2 Employees and Revenue Level of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Manufacturer
    • 6.4 Market Competition News and Trend
      • 6.4.1 Merger, Consolidation or Acquisition News
      • 6.4.2 Investment or Disinvestment News
      • 6.4.3 New Product Development and Launch

    Chapter 7 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Manufacturers Introduction and Market Data

    • 7.1 Pfizer
      • 7.1.1 Company profile
      • 7.1.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
      • 7.1.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Pfizer
    • 7.2 Novartis
      • 7.2.1 Company profile
      • 7.2.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
      • 7.2.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Novartis
    • 7.3 Bristol Myers Squibb
      • 7.3.1 Company profile
      • 7.3.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
      • 7.3.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Bristol Myers Squibb
    • 7.4 Legend Biotech
      • 7.4.1 Company profile
      • 7.4.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
      • 7.4.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Legend Biotech
    • 7.5 Sorrento Therapeutics
      • 7.5.1 Company profile
      • 7.5.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
      • 7.5.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Sorrento Therapeutics
    • 7.6 CARSGEN Therapeutics，Ltd
      • 7.6.1 Company profile
      • 7.6.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
      • 7.6.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of CARSGEN Therapeutics，Ltd
    • 7.7 Juno Therapeutics
      • 7.7.1 Company profile
      • 7.7.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
      • 7.7.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Juno Therapeutics
    • 7.8 Kite Pharma
      • 7.8.1 Company profile
      • 7.8.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
      • 7.8.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Kite Pharma
    • 7.9 Atara Biotherapeutics
      • 7.9.1 Company profile
      • 7.9.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
      • 7.9.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Atara Biotherapeutics
    • 7.10 Carina Biotech
      • 7.10.1 Company profile
      • 7.10.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
      • 7.10.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Carina Biotech
    • 7.11 Guangzhou Xiangxue Pharmaceutical
      • 7.11.1 Company profile
      • 7.11.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
      • 7.11.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Guangzhou Xiangxue Pharmaceutical

    Chapter 8 Upstream and Downstream Market Analysis of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy

    • 8.1 Industry Chain of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
    • 8.2 Upstream Market and Representative Companies Analysis
    • 8.3 Downstream Market and Representative Companies Analysis

    Chapter 9 Cost and Gross Margin Analysis of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy

    • 9.1 Cost Structure Analysis of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
    • 9.2 Raw Materials Cost Analysis of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
    • 9.3 Labor Cost Analysis of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
    • 9.4 Manufacturing Expenses Analysis of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy

    Chapter 10 Marketing Status Analysis of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy

    • 10.1 Marketing Channel
      • 10.1.1 Direct Marketing
      • 10.1.2 Indirect Marketing
      • 10.1.3 Marketing Channel Development Trend
    • 10.2 Market Positioning
      • 10.2.1 Pricing Strategy
      • 10.2.2 Brand Strategy
      • 10.2.3 Target Client
    • 10.3 Distributors/Traders List

    Chapter 11 Report Conclusion

      Chapter 12 Research Methodology and Reference

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources

      Report Summary

      Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy -Global Market Status and Trend Report 2016-2026 offers a comprehensive analysis on Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

      Worldwide and Regional Market Size of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy 2016-2021, and development forecast 2022-2026
      Main manufacturers/suppliers of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy worldwide, with company and product introduction, position in the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market
      Market status and development trend of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by types and applications
      Cost and profit status of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy , and marketing status
      Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy industry.

      The report segments the global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market as:

      Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
      North America
      Europe
      China
      Japan
      Rest APAC
      Latin America

      Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
      Allogeneic CAR T-Cells
      Autologous CAR T-Cells

      Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market: Application Segment Analysis (Consumption Volume and Market Share 2016-2026; Downstream Customers and Market Analysis)
      Hospital
      Diagnostic Center
      Others

      Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market: Manufacturers Segment Analysis (Company and Product introduction, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume, Revenue, Price and Gross Margin):
      Pfizer
      Novartis
      Bristol Myers Squibb
      Legend Biotech
      Sorrento Therapeutics
      CARSGEN Therapeutics，Ltd
      Juno Therapeutics
      Kite Pharma
      Atara Biotherapeutics
      Carina Biotech
      Guangzhou Xiangxue Pharmaceutical

      In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
      Buy now